Georgia vs Morocco: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Georgia
77.0%
in 2025
Morocco
77.0%
in 2025
Georgia rank
124th
Morocco rank
124th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Georgia
- Morocco
How they compare
Georgia currently reports 77.0% against 77.0% in Morocco, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Morocco ahead.
Georgia ranks 124th and Morocco ranks 124th of 194 countries.
Morocco has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Georgia | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 33.6% | 75.5% | 41.9% | Morocco |
| 2020s | 81.3% | 89.3% | 8.0% | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Georgia or Morocco?
- Georgia, at 77.0% against 77.0% in Morocco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Georgia and Morocco?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Morocco?
- 18 years are reported by both, from 2008 to 2025.
- How do Georgia and Morocco rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Georgia ranks 124th and Morocco ranks 124th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.